Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2003
Same author

Structure of bacteriocin AS-48: from soluble state to membrane bound state.

Journal of molecular biology·2003
Same author

Crural artery bypass with the autogenous greater saphenous vein.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2003
Same author

[Predictive value of prenatal MRI in the diagnosis of thoracic congenital malformations].

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2003
Same author

Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy.

Neoplasma·2003
Same author

Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same journal

List of guest reviewers.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same journal

An A to Z of peer-to-peer writing.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same journal

Treatment of mediastinitis following cardiac surgery-still in discussion.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same journal

Management of sterno-mediastinitis using titanium mesh following cardiac surgery.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same journal

Cerebral oxygen saturation is improved by xenon anaesthesia during carotid clamping.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same journal

Pulse pressure variation as a predictor of fluid responsiveness in mechanically ventilated patients with spontaneous breathing activity: a pragmatic observational study.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
See all related articles

Related Experiment Video

Updated: May 13, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Stentless aortic valves. Current aspects.

J Ennker1, A Albert, I C Ennker

  • 1Mediclin Heart Institute Lahr/Baden, Lahr, Germany.

HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
|February 27, 2013
PubMed
Summary
This summary is machine-generated.

Stentless heart valves offer improved hemodynamics and survival compared to stented valves. Clinical experience shows advantages in specific patient groups, with ongoing evaluation of their long-term role.

Keywords:
full root techniquestentlesssubcoronary

More Related Videos

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Related Experiment Videos

Last Updated: May 13, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Prosthetic Heart Valves

Background:

  • Stentless valve prostheses aim for physiological flow and superior hemodynamics over stented valves.
  • Generations of stentless valves have evolved, including porcine and pericardial options.
  • Various implantation techniques exist, with the full root technique minimizing patient-prosthesis mismatch.

Purpose of the Study:

  • To evaluate the hemodynamic and survival advantages of stentless bioprostheses.
  • To compare stentless valves with stented valves in clinical practice.
  • To identify patient subgroups benefiting most from stentless valve implantation.

Main Methods:

  • Review of clinical experience with over 3000 stentless valve implantations.
  • Analysis of randomized study trials comparing hemodynamic parameters.
  • Assessment of outcomes including transvalvular gradients, valve area, and left ventricular mass regression.

Main Results:

  • Randomized trials indicate hemodynamic advantages for stentless valves, though significance varies.
  • Stentless bioprostheses show benefits in transvalvular gradients, effective valve area, and left ventricular mass regression.
  • Survival advantage reported for stentless bioprostheses across literature; benefits pronounced in specific patient groups.

Conclusions:

  • Stentless valves provide significant hemodynamic and survival benefits compared to stented valves.
  • Specific patient populations, including those with reduced ejection fraction or aortic root pathology, experience greater advantages.
  • Stentless valves represent a valuable addition to surgical options, with future roles still evolving.